Feasibility of allogeneic hematopoietic stem cell transplantation for autoimmune disease: position statement from a National Institute of Allergy and Infectious Diseases and National Cancer Institute-Sponsored International Workshop, Bethesda, MD, March 12 and 13, 2005.
Griffith
Linda M
LM
Division of Allergy, Immunology and Transplantation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Pavletic
Steven Z
SZ
Tyndall
Alan
A
Bredeson
Christopher N
CN
Bowen
James D
JD
Childs
Richard W
RW
Gratwohl
Alois
A
van Laar
Jacob M
JM
Mayes
Maureen D
MD
Martin
Roland
R
McSweeney
Peter A
PA
Muraro
Paolo A
PA
Openshaw
Harry
H
Saccardi
Riccardo
R
Sandmaier
Brenda M
BM
Forman
Stephen J
SJ
Nash
Richard A
RA
D001327:Autoimmune Diseases / Q000628:therapy*; D002985:Clinical Protocols / Q000592:standards; D002986:Clinical Trials as Topic / Q000379:methods / Q000592:standards*; D004493:Education; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D006801:Humans; D009316:National Institutes of Health (U.S.); D014184:Transplantation, Homologous; D014481:United States